InvestorsHub Logo
Followers 1172
Posts 170195
Boards Moderated 4
Alias Born 12/20/2003

Re: None

Friday, 08/26/2022 10:02:26 AM

Friday, August 26, 2022 10:02:26 AM

Post# of 15975
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation ("NHSF") of its flagship product, Tilray Purified Oral Solution ("OS") CBD100, to be used in clinical trials in Australia and New Zealand.

History.htm

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TLRY News